Just one problem in vaccine enhancement is economic: Lots of the illnesses most demanding a vaccine, together with HIV, malaria and tuberculosis, exist principally in lousy nations. Pharmaceutical companies and biotechnology corporations have little incentive to build vaccines for these conditions mainly because there is small income prospective.No